Nico Stransky, Ph.D.

Nico Stransky, Ph.D.

Vice President, Data Sciences

Nico Stransky has spent the last 20 years in industry and academia at the forefront of genomics, precision medicine and translational research. As the first employee at Celsius, Nico built the computational biology, machine learning, engineering and IT/informatics groups, and focuses on applying novel computational methods to analyze large-scale single cell RNAseq data for the purpose of drug discovery and target identification.

Previously, Nico built the computational biology and bioinformatics group at Blueprint Medicines, where he led the computational efforts for target discovery, and impacted the translational medicine genomics aspects of the company’s ongoing clinical trials. Prior to Blueprint, Nico held a position in the cancer program at the Broad Institute of MIT and Harvard, where he led the computational team for the Broad-Novartis Cancer Cell Line Encyclopedia Project (CCLE) and was the lead author of one of the very first cancer exome sequencing studies.

Nico is a recognized researcher in the fields of computational biology and cancer research. He has co-authored or authored more than 40 peer-reviewed publications, nine granted patents, and has developed widely used methods and algorithms in the field of computational biology.

Nico performed his postdoctoral research at the Curie Institute in Paris, France, and obtained his Ph.D. from Paris-Saclay University. He also holds a Master’s degree in oncology and cancer therapeutics from Paris-Saclay University and a M.Sc. in biochemistry from École Normale Supérieure Paris-Saclay.